Cargando…
Tear biomarkers for Alzheimer’s disease screening and diagnosis (the TearAD study): design and rationale of an observational longitudinal multicenter study
BACKGROUND: Alzheimer’s disease (AD) is the most common cause of dementia, and due to increasing life expectancy the number of patients is expected to grow. The diagnosis of AD involves the use of biomarkers determined by an amyloid PET scan or cerebrospinal fluid analyses that are either invasive o...
Autores principales: | van de Sande, Nienke, Ramakers, Inez H. G. B., Visser, Pieter Jelle, Verhey, Frans R. J., Verbraak, Frank D., Bouwman, Femke H., Berendschot, Tos T. J. M., Nuijts, Rudy M. M. A., Webers, Carroll A. B., Gijs, Marlies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403876/ https://www.ncbi.nlm.nih.gov/pubmed/37543602 http://dx.doi.org/10.1186/s12883-023-03335-y |
Ejemplares similares
-
Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration
por: Gijs, Marlies, et al.
Publicado: (2021) -
Pre-analytical sample handling effects on tear fluid protein levels
por: Gijs, Marlies, et al.
Publicado: (2023) -
Tear biomarkers for keratoconus
por: Nishtala, Krishnatej, et al.
Publicado: (2016) -
Risk Factors for the Development of Ocular Hypertension After Keratoplasty: A Systematic Review
por: Liesenborghs, Ilona, et al.
Publicado: (2020) -
In-Depth Investigation of Conjunctival Swabs and Tear Fluid of Symptomatic COVID-19 Patients, an Observational Cohort Study
por: Gijs, Marlies, et al.
Publicado: (2021)